http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 10 Aug 2026 12:18:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++DR+REDDYS+LABORATORIES++++For%3A+Aug+07/26896436.html si-local-file:///var/storage/secattach/20260810/26896436.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++DR+REDDYS+LABORATORIES++++For%3A+Aug+07/26896436.html Mon, 10 Aug 2026 12:18:00 -0400 500124 O.00653232 RDY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++DR+REDDYS+LABORATORIES++++For%3A+Aug+07/26896436.html si-local-file:///var/storage/secattach/20260810/26896436.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++DR+REDDYS+LABORATORIES++++For%3A+Aug+07/26896436.html Mon, 10 Aug 2026 12:18:00 -0400 500124 O.00653232 RDY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++DR+REDDYS+LABORATORIES++++For%3A+Aug+07/26896436.html si-local-file:///var/storage/secattach/20260810/26896436.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++DR+REDDYS+LABORATORIES++++For%3A+Aug+07/26896436.html Mon, 10 Aug 2026 12:18:00 -0400 500124 O.00653232 RDY http://www.streetinsider.com/FDA/Dr.+Reddy%27s+launches+generic+version+of+Bridion+in+the+US/26859993.html <p>Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) has launched Sugammadex Injection 200 mg/2 mL and 500 mg/5 mL single-dose vials in the United States, a generic equivalent of Merck's Bridion, according to a press release from the company.</p> <p>The company claims the launch occurred on the first day of generic availability for the product in the U.S. market. Sugammadex Injection (100 mg/mL) is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery.</p> <p>The Bridion brand recorded U.S. sales of approximately $1.6 billion for http://www.streetinsider.com/FDA/Dr.+Reddy%27s+launches+generic+version+of+Bridion+in+the+US/26859993.html Tue, 04 Aug 2026 01:39:15 -0400 500124 A.14869825 DRREDDY O.00555950 O.00653232 RDY http://www.streetinsider.com/FDA/Dr.+Reddy%27s+launches+generic+version+of+Bridion+in+the+US/26859993.html <p>Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) has launched Sugammadex Injection 200 mg/2 mL and 500 mg/5 mL single-dose vials in the United States, a generic equivalent of Merck's Bridion, according to a press release from the company.</p> <p>The company claims the launch occurred on the first day of generic availability for the product in the U.S. market. Sugammadex Injection (100 mg/mL) is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery.</p> <p>The Bridion brand recorded U.S. sales of approximately $1.6 billion for http://www.streetinsider.com/FDA/Dr.+Reddy%27s+launches+generic+version+of+Bridion+in+the+US/26859993.html Tue, 04 Aug 2026 01:39:15 -0400 500124 A.14869825 DRREDDY O.00555950 O.00653232 RDY http://www.streetinsider.com/FDA/Dr.+Reddy%27s+launches+generic+version+of+Bridion+in+the+US/26859993.html <p>Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) has launched Sugammadex Injection 200 mg/2 mL and 500 mg/5 mL single-dose vials in the United States, a generic equivalent of Merck's Bridion, according to a press release from the company.</p> <p>The company claims the launch occurred on the first day of generic availability for the product in the U.S. market. Sugammadex Injection (100 mg/mL) is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery.</p> <p>The Bridion brand recorded U.S. sales of approximately $1.6 billion for http://www.streetinsider.com/FDA/Dr.+Reddy%27s+launches+generic+version+of+Bridion+in+the+US/26859993.html Tue, 04 Aug 2026 01:39:15 -0400 500124 A.14869825 DRREDDY O.00555950 O.00653232 RDY http://www.streetinsider.com/FDA/Dr.+Reddy%27s+launches+generic+version+of+Bridion+in+the+US/26859993.html <p>Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) has launched Sugammadex Injection 200 mg/2 mL and 500 mg/5 mL single-dose vials in the United States, a generic equivalent of Merck's Bridion, according to a press release from the company.</p> <p>The company claims the launch occurred on the first day of generic availability for the product in the U.S. market. Sugammadex Injection (100 mg/mL) is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery.</p> <p>The Bridion brand recorded U.S. sales of approximately $1.6 billion for http://www.streetinsider.com/FDA/Dr.+Reddy%27s+launches+generic+version+of+Bridion+in+the+US/26859993.html Tue, 04 Aug 2026 01:39:15 -0400 500124 A.14869825 DRREDDY O.00555950 O.00653232 RDY http://www.streetinsider.com/FDA/Dr.+Reddy%27s+launches+generic+version+of+Bridion+in+the+US/26859993.html <p>Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) has launched Sugammadex Injection 200 mg/2 mL and 500 mg/5 mL single-dose vials in the United States, a generic equivalent of Merck's Bridion, according to a press release from the company.</p> <p>The company claims the launch occurred on the first day of generic availability for the product in the U.S. market. Sugammadex Injection (100 mg/mL) is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery.</p> <p>The Bridion brand recorded U.S. sales of approximately $1.6 billion for http://www.streetinsider.com/FDA/Dr.+Reddy%27s+launches+generic+version+of+Bridion+in+the+US/26859993.html Tue, 04 Aug 2026 01:39:15 -0400 500124 A.14869825 DRREDDY O.00555950 O.00653232 RDY http://www.streetinsider.com/FDA/Dr.+Reddy%27s+launches+generic+version+of+Bridion+in+the+US/26859993.html <p>Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) has launched Sugammadex Injection 200 mg/2 mL and 500 mg/5 mL single-dose vials in the United States, a generic equivalent of Merck's Bridion, according to a press release from the company.</p> <p>The company claims the launch occurred on the first day of generic availability for the product in the U.S. market. Sugammadex Injection (100 mg/mL) is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery.</p> <p>The Bridion brand recorded U.S. sales of approximately $1.6 billion for http://www.streetinsider.com/FDA/Dr.+Reddy%27s+launches+generic+version+of+Bridion+in+the+US/26859993.html Tue, 04 Aug 2026 01:39:15 -0400 500124 A.14869825 DRREDDY O.00555950 O.00653232 RDY http://www.streetinsider.com/Press+Releases/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html <p> HYDERABAD, India &amp; PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a generic equivalent of Bridion®, in the United States (US), expanding its hospital portfolio and reinforcing its commitment to improving patient access to affordable, high-quality medicines. </p><p> Sugammadex Injection is a vertically integrated product manufactured through Dr. Reddy's global supply network. Dr. Reddy's launch of the product is on the first day of http://www.streetinsider.com/Press+Releases/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html Tue, 04 Aug 2026 01:39:00 -0400 500124 A.14869825 DRREDDY O.00555950 O.00653232 RDY http://www.streetinsider.com/Press+Releases/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html <p> HYDERABAD, India &amp; PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a generic equivalent of Bridion®, in the United States (US), expanding its hospital portfolio and reinforcing its commitment to improving patient access to affordable, high-quality medicines. </p><p> Sugammadex Injection is a vertically integrated product manufactured through Dr. Reddy's global supply network. Dr. Reddy's launch of the product is on the first day of http://www.streetinsider.com/Press+Releases/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html Tue, 04 Aug 2026 01:39:00 -0400 500124 A.14869825 DRREDDY O.00555950 O.00653232 RDY http://www.streetinsider.com/Press+Releases/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html <p> HYDERABAD, India &amp; PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a generic equivalent of Bridion®, in the United States (US), expanding its hospital portfolio and reinforcing its commitment to improving patient access to affordable, high-quality medicines. </p><p> Sugammadex Injection is a vertically integrated product manufactured through Dr. Reddy's global supply network. Dr. Reddy's launch of the product is on the first day of http://www.streetinsider.com/Press+Releases/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html Tue, 04 Aug 2026 01:39:00 -0400 500124 A.14869825 DRREDDY O.00555950 O.00653232 RDY http://www.streetinsider.com/Press+Releases/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html <p> HYDERABAD, India &amp; PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a generic equivalent of Bridion®, in the United States (US), expanding its hospital portfolio and reinforcing its commitment to improving patient access to affordable, high-quality medicines. </p><p> Sugammadex Injection is a vertically integrated product manufactured through Dr. Reddy's global supply network. Dr. Reddy's launch of the product is on the first day of http://www.streetinsider.com/Press+Releases/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html Tue, 04 Aug 2026 01:39:00 -0400 500124 A.14869825 DRREDDY O.00555950 O.00653232 RDY http://www.streetinsider.com/Press+Releases/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html <p> HYDERABAD, India &amp; PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a generic equivalent of Bridion®, in the United States (US), expanding its hospital portfolio and reinforcing its commitment to improving patient access to affordable, high-quality medicines. </p><p> Sugammadex Injection is a vertically integrated product manufactured through Dr. Reddy's global supply network. Dr. Reddy's launch of the product is on the first day of http://www.streetinsider.com/Press+Releases/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html Tue, 04 Aug 2026 01:39:00 -0400 500124 A.14869825 DRREDDY O.00555950 O.00653232 RDY http://www.streetinsider.com/Press+Releases/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html <p> HYDERABAD, India &amp; PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a generic equivalent of Bridion®, in the United States (US), expanding its hospital portfolio and reinforcing its commitment to improving patient access to affordable, high-quality medicines. </p><p> Sugammadex Injection is a vertically integrated product manufactured through Dr. Reddy's global supply network. Dr. Reddy's launch of the product is on the first day of http://www.streetinsider.com/Press+Releases/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html Tue, 04 Aug 2026 01:39:00 -0400 500124 A.14869825 DRREDDY O.00555950 O.00653232 RDY http://www.streetinsider.com/Business+Wire/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html <p> HYDERABAD, India &amp; PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a generic equivalent of Bridion®, in the United States (US), expanding its hospital portfolio and reinforcing its commitment to improving patient access to affordable, high-quality medicines. </p><p> Sugammadex Injection is a vertically integrated product manufactured through Dr. Reddy's global supply network. Dr. Reddy's launch of the product is on the first day of http://www.streetinsider.com/Business+Wire/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html Tue, 04 Aug 2026 01:39:00 -0400 500124 A.14869825 DRREDDY O.00555950 O.00653232 RDY http://www.streetinsider.com/Business+Wire/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html <p> HYDERABAD, India &amp; PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a generic equivalent of Bridion®, in the United States (US), expanding its hospital portfolio and reinforcing its commitment to improving patient access to affordable, high-quality medicines. </p><p> Sugammadex Injection is a vertically integrated product manufactured through Dr. Reddy's global supply network. Dr. Reddy's launch of the product is on the first day of http://www.streetinsider.com/Business+Wire/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html Tue, 04 Aug 2026 01:39:00 -0400 500124 A.14869825 DRREDDY O.00555950 O.00653232 RDY http://www.streetinsider.com/Business+Wire/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html <p> HYDERABAD, India &amp; PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a generic equivalent of Bridion®, in the United States (US), expanding its hospital portfolio and reinforcing its commitment to improving patient access to affordable, high-quality medicines. </p><p> Sugammadex Injection is a vertically integrated product manufactured through Dr. Reddy's global supply network. Dr. Reddy's launch of the product is on the first day of http://www.streetinsider.com/Business+Wire/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html Tue, 04 Aug 2026 01:39:00 -0400 500124 A.14869825 DRREDDY O.00555950 O.00653232 RDY http://www.streetinsider.com/Business+Wire/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html <p> HYDERABAD, India &amp; PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a generic equivalent of Bridion®, in the United States (US), expanding its hospital portfolio and reinforcing its commitment to improving patient access to affordable, high-quality medicines. </p><p> Sugammadex Injection is a vertically integrated product manufactured through Dr. Reddy's global supply network. Dr. Reddy's launch of the product is on the first day of http://www.streetinsider.com/Business+Wire/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html Tue, 04 Aug 2026 01:39:00 -0400 500124 A.14869825 DRREDDY O.00555950 O.00653232 RDY http://www.streetinsider.com/Business+Wire/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html <p> HYDERABAD, India &amp; PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a generic equivalent of Bridion®, in the United States (US), expanding its hospital portfolio and reinforcing its commitment to improving patient access to affordable, high-quality medicines. </p><p> Sugammadex Injection is a vertically integrated product manufactured through Dr. Reddy's global supply network. Dr. Reddy's launch of the product is on the first day of http://www.streetinsider.com/Business+Wire/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html Tue, 04 Aug 2026 01:39:00 -0400 500124 A.14869825 DRREDDY O.00555950 O.00653232 RDY http://www.streetinsider.com/Business+Wire/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html <p> HYDERABAD, India &amp; PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a generic equivalent of Bridion®, in the United States (US), expanding its hospital portfolio and reinforcing its commitment to improving patient access to affordable, high-quality medicines. </p><p> Sugammadex Injection is a vertically integrated product manufactured through Dr. Reddy's global supply network. Dr. Reddy's launch of the product is on the first day of http://www.streetinsider.com/Business+Wire/Dr.+Reddy%E2%80%99s+Announces+the+First-to-Market+Launch+of+Sugammadex+Injection+200+mg2+mL+%28100+mgmL%29+and+500+mg5+mL+%28100+mgmL%29+Single-Dose+Vials%2C+a+Generic+Equivalent+of+Bridion%C2%AE%2C+in+the+United+State/26859992.html Tue, 04 Aug 2026 01:39:00 -0400 500124 A.14869825 DRREDDY O.00555950 O.00653232 RDY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++DR+REDDYS+LABORATORIES++++For%3A+Aug+01/26853374.html si-local-file:///var/storage/secattach/20260803/26853374.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++DR+REDDYS+LABORATORIES++++For%3A+Aug+01/26853374.html Mon, 03 Aug 2026 06:25:00 -0400 500124 O.00653232 RDY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++DR+REDDYS+LABORATORIES++++For%3A+Aug+01/26853374.html si-local-file:///var/storage/secattach/20260803/26853374.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++DR+REDDYS+LABORATORIES++++For%3A+Aug+01/26853374.html Mon, 03 Aug 2026 06:25:00 -0400 500124 O.00653232 RDY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++DR+REDDYS+LABORATORIES++++For%3A+Aug+01/26853374.html si-local-file:///var/storage/secattach/20260803/26853374.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++DR+REDDYS+LABORATORIES++++For%3A+Aug+01/26853374.html Mon, 03 Aug 2026 06:25:00 -0400 500124 O.00653232 RDY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++DR+REDDYS+LABORATORIES++++For%3A+Jul+29/26833817.html si-local-file:///var/storage/secattach/20260729/26833817.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++DR+REDDYS+LABORATORIES++++For%3A+Jul+29/26833817.html Wed, 29 Jul 2026 14:00:00 -0400 500124 O.00653232 RDY